Skip to main content
. 2022 Jul 7;7(8):1161–1179. doi: 10.1038/s41564-022-01143-7

Extended Data Fig. 3. HCoV reactivity following third dose of SARS-CoV-2 vaccine.

Extended Data Fig. 3

Antibody responses were studied in four groups of individuals primed with two doses of either ChAdOx1 or BNT162b2, followed by a booster of BNT162b2 or mRNA-1273. Responses were measured by MSD-ECL assay against full-length spike glycoprotein (Spike) from HCoVs 229E, OC43, NL63 and HKU1 and are expressed as MSD arbitrary units (AU/ml). Bar represents group mean.

Source data